(Q83238029)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

A Gratwohl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

H Baldomero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

A Schwendener

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

V Rocha

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J Apperley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

K Frauendorfer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

D Niederwieser

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Joint Accreditation Committee of the International Society for Cellular Therapy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

European Group for Blood and Marrow Transplantation

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

26 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

275-291

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19169283%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2009.7

20 January 2020

exact match

0 references

cites work

Current trends in hematopoietic stem cell transplantation in Europe

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Predictability of hematopoietic stem cell transplantation rates

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Stem cell therapy in myocardial repair and remodeling

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Cell therapy for ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

The changing face of neural stem cell therapy in neurologic diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Potential of mesenchymal stem cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Stem cells and rheumatology: update on adult stem cell therapy in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Hematopoietic stem cell transplantation in adults with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Hematopoietic cell transplantation for patients with myelodysplastic syndromes (MDS): when, how and for whom?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

Allogeneic stem cell transplantation for myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.7

7 January 2021